Annual Retained Earnings
-$154.45 M
-$71.58 M-86.39%
December 31, 2023
Summary
- As of February 26, 2025, ELVN annual retained earnings is -$154.45 million, with the most recent change of -$71.58 million (-86.39%) on December 31, 2023.
- During the last 3 years, ELVN annual retained earnings has fallen by -$133.99 million (-654.80%).
- ELVN annual retained earnings is now -654.80% below its all-time high of -$20.46 million, reached on December 1, 2020.
Performance
ELVN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$220.29 M
-$23.16 M-11.75%
September 30, 2024
Summary
- As of February 26, 2025, ELVN quarterly retained earnings is -$220.29 million, with the most recent change of -$23.16 million (-11.75%) on September 30, 2024.
- Over the past year, ELVN quarterly retained earnings has dropped by -$43.11 million (-24.33%).
- ELVN quarterly retained earnings is now -387.35% below its all-time high of -$45.20 million, reached on December 1, 2021.
Performance
ELVN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ELVN Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -86.4% | -24.3% |
| 3 y3 years | -654.8% | -125.7% |
| 5 y5 years | -654.8% | -125.7% |
ELVN Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -241.7% | at low | -387.4% | at low |
| 5 y | 5-year | -654.8% | at low | -387.4% | at low |
| alltime | all time | -654.8% | at low | -387.4% | at low |
Enliven Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$220.29 M(+11.7%) |
| Jun 2024 | - | -$197.14 M(+11.3%) |
| Mar 2024 | - | -$177.19 M(+14.7%) |
| Dec 2023 | -$154.45 M | -$154.45 M(+14.3%) |
| Sep 2023 | - | -$135.08 M(+18.2%) |
| Jun 2023 | - | -$114.31 M(+17.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$97.59 M(+17.8%) |
| Dec 2022 | -$82.86 M(+83.3%) | -$82.86 M(+13.0%) |
| Sep 2022 | - | -$73.31 M(+62.2%) |
| Dec 2021 | -$45.20 M(+120.9%) | - |
| Dec 2021 | - | -$45.20 M |
| Dec 2020 | -$20.46 M | - |
FAQ
- What is Enliven Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Enliven Therapeutics?
- What is Enliven Therapeutics annual retained earnings year-on-year change?
- What is Enliven Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly retained earnings year-on-year change?
What is Enliven Therapeutics annual retained earnings?
The current annual retained earnings of ELVN is -$154.45 M
What is the all time high annual retained earnings for Enliven Therapeutics?
Enliven Therapeutics all-time high annual retained earnings is -$20.46 M
What is Enliven Therapeutics annual retained earnings year-on-year change?
Over the past year, ELVN annual retained earnings has changed by -$71.58 M (-86.39%)
What is Enliven Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ELVN is -$220.29 M
What is the all time high quarterly retained earnings for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly retained earnings is -$45.20 M
What is Enliven Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ELVN quarterly retained earnings has changed by -$43.11 M (-24.33%)